GARDP NORTH AMERICA INC

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2021

Legal Domicile

Principal Officer

ANDREW GOLDMAN

Phone

2158648175

Tax Period

2023-01-01 to 2023-12-31

GARDP NORTH AMERICA INC, founded in 2021, is a micro nonprofit that reported $3K in total revenue in fiscal year 2023. Revenue fell 99% from the prior year — a significant decline worth monitoring. Expenses of $225K exceeded revenue, resulting in a 7088% operating deficit.

Mission

GARDP NA WAS ORGANIZED TO OPERATE AND CONDUCT ACTIVITIES IN THE UNITED STATES THAT CONTRIBUTE TO THE DEVELOPMENT OF NEW HEALTH TECHNOLOGIES TO FIGHT AGAINST ANTIMICROBIAL RESISTANCE ("AMR") AND TO FOSTER APPROPRIATE USE AND ENHANCE ACCESS TO SUCH TECHNOLOGIES.

Program Service Accomplishments

Program 1

Expenses: $199,983

GARDP NA WAS INCORPORATED IN MAY 2021. ACTIVITIES TO DATE HAVE INCLUDED INITIAL ORGANIZATIONAL MATTERS AND KICK OFF OF PROGRAMMATIC ACTIVITIES.GARDP NA HAS INITIATED THE FOLLOWING, CONSISTENT WITH...

GARDP NA WAS INCORPORATED IN MAY 2021. ACTIVITIES TO DATE HAVE INCLUDED INITIAL ORGANIZATIONAL MATTERS AND KICK OFF OF PROGRAMMATIC ACTIVITIES.GARDP NA HAS INITIATED THE FOLLOWING, CONSISTENT WITH OUR BUSINESS PLAN:1) INITIATED FUNDRAISING AND GRANT MAKING OUTREACH TO SUPPORT RESEARCH AND DEVELOPMENT ("R&D") AND OTHER PROGRAMS AIMED AT COMBATING ANTIMICROBIAL RESISTANCE;2) BEGAN RAISING AWARENESS OF AND FOSTERING PUBLIC APPRECIATION AND UNDERSTANDING OF ANTIMICROBIAL RESISTANCE AND ASSOCIATED PUBLIC HEALTH ISSUES AMONG POLICY MAKERS, THE MEDIA, AND PRIVATE SECTOR, CIVIL SOCIETY AND GOVERNMENTAL BODIES, THE GENERAL PUBLIC AND OTHER RELEVANT STAKEHOLDERS; RAISING AWARENESS OF THE NEED TO INVEST IN R&D AND SUSTAINABLE AND EQUITABLE ACCESS PROGRAMS IN THE FIELD OF ANTIMICROBIAL RESISTANCE, AND ADVOCATING FOR THE ADOPTION OF POLICIES FAVORABLE TO SUCH INVESTMENT IN THE FIELD OF ANTIMICROBIAL RESISTANCE, CONSISTENT WITH GARDP NA'S STATUS UNDER SECTION 501(C)(3) OF THE CODE AND SUBJECT TO THE APPLICABLE LIMITATIONS AND RESTRICTIONS UNDER THE CODE.3) SUPPORTED OTHER RELEVANT GLOBAL OR REGIONAL INITIATIVES IN PUBLIC HEALTH, WITH A FOCUS ON ANTIMICROBIAL RESISTANCE, INCLUDING COOPERATION WITH AND FACILITATION OF STRATEGIC AND COLLABORATIVE RELATIONSHIPS AMONG POLICYMAKERS, ACADEMIC AND RESEARCH INSTITUTIONS, DIAGNOSTIC, PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, PHILANTHROPIC INSTITUTIONS, CIVIL SOCIETY AND OTHER ORGANIZATIONS, WHETHER LOCAL, NATIONAL, OR INTERNATIONAL.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $0

Program Service Revenue $0

Investment Income $0

Other Revenue $3,137

TOTAL REVENUE $3,137

Expense Breakdown

Grants Paid $0

Salaries & Benefits $59,194

Fundraising Expenses $0

Program Expenses $199,983

Other Expenses $166,304

TOTAL EXPENSES $225,498

Year-over-Year Comparison

	2023	2022	Change
Revenue	$3,137	$296,027	-1.0%
Expenses	$225,498	$888,818	-0.7%
Net Income	$-222,361	$-592,791	-0.6%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✓ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

Governance Policies

✓ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$169,952

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
SARA COSGROVE	CHAIR	1.00	Officer Director	$0	$0	$0
PRABHAVATHI FERNANDES	TREASURER	1.00	Officer Director	$0	$0	$0
PAUL MODEL	SECRETARY	1.00	Officer Director	$0	$0	$0
JIMMY KOLKER	DIRECTOR	1.00	Director	$0	$0	$0
KAREN M LINEHAN	DIRECTOR	1.00	Director	$0	$0	$0
ANDREW BETTS	EXECUTIVE DIRECTOR	40.00	Officer	$152,450	$17,502	$169,952
SUBASREE SRINIVASAN	MEDICAL DIRECTOR	40.00	Highest	$287,386	$48,096	$335,482

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	No data	No data	No data	No data
2023	$3,137	$225,498	$112,657	$-222,361
2022	$296,027	$888,818	$368,915	$-592,791
2021	$1,104,000	$223,346	$898,589	$880,654